mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
-0.1 |
0.08 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.08 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.059 |
0.08 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.08 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.08 |
mRNA |
S-Trityl-L-cysteine |
FIMM |
pan-cancer |
AAC |
0.32 |
0.08 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.08 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.08 |
mRNA |
QL-X-138 |
GDSC1000 |
pan-cancer |
AAC |
-0.055 |
0.08 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.09 |